跳至主要内容
临床试验/NCT03757052
NCT03757052Unknown不适用

Safety, Validity and Efficiency of a Direct Graded Oral Challenge With Amoxicillin for the Evaluation of Penicillin Allergy in Adults

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年11月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
Type 1 Hypersensitivity Reaction

研究概览

简要总结

False diagnosis of penicillin allergy are frequently reported, and have been proven detrimental to patients. Current guidelines for the assessment of drug allergies recommend that penicillin allergy be evaluated first with prick and intradermal skin tests, and then completed with a graded oral challenge, spread over at least two doses. However, it has been shown that these skin tests, in addition to consuming resources and time, are of limited, or even doubtful validity, given the poor predictive values that have been reported in the modern penicillins era. It now seems unreasonable to continue their use without addressing other, more efficient diagnostic stategies. Several groups have now demonstrated the safety, validity, and efficiency of a direct, two-step amoxicillin oral challenge (starting with 10% of the standard therapeutic dose, followed by 90 % of the dose), without prior skin tests, first for any type of reaction in the pediatric population, then for any non-immediate reaction in the adult population. The objective of this study is to demonstrate the safety, efficiency, and validity of direct, two-step graded oral challenge with amoxicillin for the evaluation of any reported penicillin allergy in the adult population, excluding high-risk patients (documented anaphylaxis to a penicillin in the last 5 years). Skin tests will first be performed according to the protocol currently in use at the CHUL, then consented patients will proceed with the graded oral challenge still according to the protocol currently in use at the CHUL, but regardless of the skin tests results. The results of the two tests will be compared to determine the safety, efficiency and validity of proceeding directly to the graded oral challenge.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being 18 years of age or older at the time of the test
  • Being referred by a health professional for the evaluation of any allergic reaction to a penicillin, including natural penicillins, anti-staphylococcal penicillins, aminopenicillins, penicillins combined with a beta-lactamase inhibitor, and carboxypenicillins ; or an antibiotic of the beta-lactam family, whose assessment requires testing for penicillins, according to the treating allergist

排除标准

  • Pregnancy
  • Poorly controlled asthma, chronic lung disease or heart disease
  • Failure to stop beta-blockers prior to the test
  • Occurrence of the reaction in the 4 weeks preceding the test (possibility of false negatives)
  • History of severe delayed hypersensitivity reaction, reaction requiring hospitalization of more than 24 hours, or bullous, pustular, exfoliative or mucosal reaction (excluding angioedema)
  • Recent anaphylaxis (<5 years), defined as concomitant involvement of at least two systems (respiratory, digestive, mucocutaneous or cardiovascular) within one hour of administration of the drug

研究组 & 干预措施

Skin testing and Graded Oral Challenge

Experimental

Penicillin skin testing as described in the intervention section, followed by amoxicillin graded oral challenge as described in the intervention section

干预措施: Penicillin Skin Testing (Diagnostic Test)

结局指标

主要结局

Type 1 Hypersensitivity Reaction

时间窗: 60 minutes

The primary outcome is the occurrence of immediate hypersensitivity symptoms, occuring during the test period, which is up to 60 minutes after the last dose of amoxicillin.

次要结局

  • Delayed hypersensitivity symptoms(14 days)
  • Severity of immediate hypersensitivity symptoms(60 minutes)
  • Skin Tests Results(60 minutes)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验